Lexaria Bioscience Corp. — Director's Dealing 2009

Mar 7, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRA)
CIK: 0001348362
Period of Report: 2009-03-04

Reporting Person: MacMillan Leonard (Director, Vice President-Corp Develop)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-04	Stock Options	$0.12	A	200000	Acquired	2011-07-20	Common Shares (200000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.8	2011-04-26	Comnmon Shares (200000)	200000	Direct

Footnotes

F1: On June 19, 2007, the exercise price was reduced from $1.30.